Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006899 |
---|---|
Receipt number | R000008143 |
Scientific Title | Randomized phase II study of biweekly cetuximab versus panitumumab in patients not combination of irinotecan wild-type KRAS metastatic colorectal cancer following treatment with fluoropyrimidine and oxaliplatin chemotherapy |
Date of disclosure of the study information | 2011/12/19 |
Last modified on | 2014/06/17 14:14:02 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/12/17 14:49:08 | ||
2 | Update | 2012/01/06 19:20:48 | Acronym Acronym |
|
3 | Update | 2013/12/17 13:11:35 | Email Organization Organization Address Address TEL Organization Organization Address Address TEL |
|
4 | Update | 2014/06/17 14:14:02 | Recruitment status |